A comprehensive analysis of biological clocks across the human body reveals that both insufficient and excessive sleep are associated with accelerated aging in nearly every organ system.
Tumor Metabolism: The Central Integrating Node of the 2026 Cancer Hallmarks
Open Access
https://t.co/9S0puMINir
In January 2026, Douglas Hanahan updated the "Cancer Hallmarks" framework. Our recent commentary in The Innovation Nutrition argues that tumor metabolism is no longer just a classic hallmark, but the "universal language" linking all dimensions of cancer biology.
By positioning metabolic reprogramming at the center, we bridge FOUR critical dimensions:
1. Core Hallmarks: Metabolism fuels proliferation and facilitates immune evasion via lactate-mediated acidification.
2. Enabling Characteristics: It acts as a master conductor of epigenetic changes and is the "behind-the-scenes driver" of phenotypic plasticity.
3. Microenvironmental Cells: The TME functions as a metabolic ecosystem where cancer cells and stromal cells (like CAFs) engage in "metabolic collaboration".
4. Systemic Interactions: We highlight the emerging roles of neural regulation, the gut microbiome, and systemic conditions like cachexia in tumor progression.
This multidimensional perspective provides a theoretical foundation for "Hallmark-guided personalized therapy".
By co-targeting metabolic nodes alongside other hallmarks, we can overcome therapy resistance and move toward true precision oncology.
#Cancer #CancerResearch #metabolism #Hallmark #Science #ASCO26 #TumorEnvironment #metastasis #news #TME #oncology #CAFs
G-spot found in penis
A long-overlooked area of the penis has been found to have the highest concentration of nerve endings and sensory structures in the organ, suggesting that it is the “male G-spot”
DZD6008: A Fourth-Generation EGFR TKI Overcomes Resistance Following Third-Generation EGFR TKI Failure. @ASCO#ASCO26
DZD6008 demonstrated strong and durable anti-tumor activity in patients relapsed from third-generation EGFR TKI with a favorable safety profile.
Our #ASCO26 highlights: Oral data for DZD6008 demonstrating strong and durable anti-tumor activity and excellent BBB penetration following third-generation EGFR TKIs.
https://t.co/6MNLwgL614
#NSCLC#oncology#EGFR